Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 2/20 | 0.47 |
| ▸ | RXRB | P28702 | 2/20 | 0.47 |
| ▸ | RXRG | P48443 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | RGS12 | O14924 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3297493 | 0.98 | AKR1B1 (0.46) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL585478 | 0.87 | HCAR1 (0.50) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL1401565 | 0.87 | CYP4F2 (0.49) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL867785 | 0.85 | AGBL2 (0.43) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL156863 | 0.85 | FFAR4 (0.43) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL1244833 | 0.85 | RXRA (0.41) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL27830212 | 0.85 | RXRA (0.41) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL10241639 | 0.85 | THRB (0.43) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL1560270 | 0.85 | AKR1B1 (0.49) | AKR1B1RXRARXRBRXRGLMNA | |
| SCHEMBL5907106 | 0.82 | MEN1 (0.41) | RXRARXRBRXRGNR3C1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527108-B | Process for preparing optically pure 5, 7-difluoro-1, 2,3, 4-tetrahydronaphthalen-2-amine and salts thereof | 斯芬克司药物研发（天津）股份有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-109809383-B | Synthesis method of cabbage black rot pathogen resistant selenium carbon material | 扬州大学 | 2022-03-22 | — | — | CN | claimed |
| CN-113527108-A | Process for preparing optically pure 5, 7-difluoro-1, 2,3, 4-tetrahydronaphthalen-2-amine and salts thereof | 斯芬克司药物研发（天津）股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-111018663-A | Nepitastat important intermediate and enzyme catalytic synthesis method thereof | 苏州凯瑞医药科技有限公司 | 2020-04-17 | — | — | CN | claimed |
| EP-3114715-B1 | P-DOPING CROSS-LINKING OF ORGANIC HOLE TRANSPORTERS | SIEMENS AG (DE) | 2019-10-30 | — | — | EP | claimed |
| CN-109809383-A | A kind of synthetic method of anti-cabbage black rot bacterium selenium carbon material | 扬州大学 | 2019-05-28 | — | — | CN | claimed |
| CN-106631728-A | Method for preparing 3,5-difluorobenzaldehyde by 3,5-difluorotoluene continuous oxidation | 常州大学 | 2017-05-10 | — | — | CN | claimed |
| CN-102797043-B | Medicinal molecular fragment library and construction process thereof | Tianli (Tianjin) Technology Co., Ltd. (CN) | 2015-11-25 | — | — | CN | claimed |
| CN-103058931-B | Four 2-(3', 5'-dihalo-benzyl) benzimidazole type novel compounds and preparation method thereof | GUANGDONG TONESET SCIENCE & TECHNOLOGY CO LTD | 2015-07-01 | — | — | CN | claimed |
| CN-102797043-A | Medicinal molecular fragment library and construction method thereof | CBB NETWORK CO LTD | 2012-11-28 | — | — | CN | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7276496-B2 | Cyclic malonamides as inhibitors of Aβ protein protection | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-10-02 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-5744273-A | Laminatable backing substrates containing fluoro compounds for improved toner flow | XEROX CORPORATION (US) | 1998-04-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | AKR1B1 1963/4885RXRA 577/4885RXRB 407/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | AKR1B1 2784/4885RXRA 761/4885RXRB 1343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.